Global Markets for Generic Drugs

Published - Jan 2014| Analyst - Paul Evers| Code - PHM009G
Market Research Report Single User License: $4655

Report Highlights

The global generics sector reached $269.8 billion in 2012. This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.

Report Includes

  • An overview of the global market for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs (e.g., hypolipidaemics and antihypertensives), and drugs for respiratory conditions, including asthma and COPD.
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Examination of strategies employed by companies specializing in generics to meet the challenges of this highly competitive market, while also summarizing strategies employed by “originator” companies to forestall generic competition.
  • Discussion of important trends by product categories and major country markets, acknowledging that Brazil, China, India, Mexico, and Russia are among the rising markets for generic activity.
  • Comprehensive profiles of leading generics companies, and updates on mergers and acquisitions.

SCOPE OF REPORT

This report discusses the implications of all the above-mentioned trends, in the context of the current size and growth of the generics market, both in global terms and analyzed by the most important national markets. The nature and structure of the generics industry is discussed, with profiles of the leading 20-plus generics companies, and an update on mergers and acquisitions (M&A) activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

ANALYST CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of two previous reports on the generics marketplace as well as analyses of major therapeutic categories and the pharmaceutical regulatory environment.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at(+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price
Full Report: Global Markets for Generic Drugs 197 $4655
Chapter- 1: INTRODUCTION 3 Free Download
Chapter- 2: SUMMARY 3 $250
Chapter- 3: OVERVIEW 6 $213
Chapter- 4: THE NEW GENERICS ERA 16 $567
Chapter- 5: MAJOR GENERIC ISSUES 18 $638
Chapter- 6: THE GENERIC MARKET 24 $851
Chapter- 7: THE GLOBAL GENERICS INDUSTRY 5 $177
Chapter- 8: PROFILES OF TOP TEN GENERICS COMPANIES 20 $709
Chapter- 9: OTHER INTERNATIONAL GENERICS COMPANIES 29 $1028
Chapter- 10: THE AMERICAN REGION 25 $886
Chapter- 11: THE ASIAN REGION 22 $780
Chapter- 12: THE EUROPEAN REGION 26 $922
List of Tables
List of Figures
Download Table of Contents
RELATED REPORTS
Share This Report